Cross-manager
Summary
134 of 137 filed constant set 133 2024 Q2 → 2024 Q3 dollar-sum holdings as of 30 Sep 2024 as of today
2024 Q3
134 of 137 filedsectors · dollar-sum
?
Quarter-aligned featured master book. Pie is 100% of mapped names. The hole is mapped share of full AUM. Unmapped names stay blank, never Other. mapped + unmapped ≤ 100 — options sit in the denominator. pie is that mapped slice, not the book.
Waterfall reads left to right: start, each sector’s Δ, then the end. Green is up, red is down. Equal-weight is mix-shift of the mapped pie; dollar-sum is mapped dollars. axis zoomed to the move.
Grid is each manager’s latest 13F (mixed dates). Long equity only. Dollars across the constant set.
| include | sector | mix |
|---|---|---|
| Communication Services | 9.0% | |
| Consumer Discretionary | 9.8% | |
| Consumer Staples | 5.7% | |
| Energy | 5.5% | |
| Financials | 22.3% | |
| Health Care | 10.6% | |
| Industrials | 10.2% | |
| Information Technology | 21.8% | |
| Materials | 2.1% | |
| Real Estate | 1.8% | |
| Utilities | 1.2% |
95.1% of full AUM is mapped unmapped 2.0% all names
2024 Q2 → 2024 Q3 up down
1 new in 2024 Q3
excluded from Δ: Rule One Partners.
| sector | 2024 Q2 | 2024 Q3 | Δ | $ 2024 Q3 |
|---|---|---|---|---|
| Communication Services | 9.1% | 9.0% | −0.15% | $121.7B |
| Consumer Discretionary | 9.2% | 9.8% | +0.59% | $132.7B |
| Consumer Staples | 5.5% | 5.7% | +0.21% | $77.6B |
| Energy | 6.2% | 5.5% | −0.72% | $74.8B |
| Financials | 22.2% | 22.3% | +0.03% | $301.5B |
| Health Care | 10.2% | 10.6% | +0.42% | $143.5B |
| Industrials | 9.6% | 10.2% | +0.65% | $138.5B |
| Information Technology | 23.6% | 21.8% | −1.79% | $294.9B |
| Materials | 1.8% | 2.1% | +0.29% | $29B |
| Real Estate | 1.5% | 1.8% | +0.30% | $24.2B |
| Utilities | 1.0% | 1.2% | +0.17% | $16.4B |
?
Share-count breadth; splits look like Adds. Direction is Δ dollar-sum. Names lead with |Δ|. Among owners is holders only. Dollars across the constant set. GOOG / GOOGL is one name; holders stay per class. Add/Reduce on a grouped row is —. Check sectors to mix names.
Health Care · 347 shown · 134 of 137 filed · dollar-sum
| ticker | issuer | owners | weight | among owners | Δ weight | new | add | reduce | exit |
|---|---|---|---|---|---|---|---|---|---|
| HCA | Hca Healthcare Inc. |
11 |
0.53% | 3.1% | +0.10% | 1 | 3 | 5 | 1 |
| BAX | Baxter International, Inc. |
8 |
0.23% | 1.3% | +0.06% | 0 | 4 | 3 | 0 |
| HUM | Humana, Inc. |
8 |
0.25% | 1.6% | −0.05% | 1 | 4 | 2 | 4 |
| DVA | Davita Inc. |
3 |
0.42% | 0.89% | +0.05% | 0 | 1 | 1 | 1 |
| MDT | Medtronic PLC |
10 |
0.19% | 1.4% | −0.05% | 0 | 5 | 5 | 0 |
| CVS | Cvs Health Corp. |
14 |
0.45% | 3.0% | +0.05% | 1 | 8 | 5 | 1 |
| ELV | Elevance Health Inc. |
12 |
0.39% | 3.7% | −0.04% | 0 | 5 | 5 | 2 |
| SNY | Sanofi SA |
7 |
0.32% | 1.3% | +0.04% | 1 | 3 | 3 | 1 |
| GEHC | Ge Healthcare Technologies, Inc. |
9 |
0.19% | 2.5% | +0.04% | 1 | 2 | 5 | 1 |
| MCK | Mckesson Corp. |
4 |
0.03% | 5.9% | −0.03% | 0 | 2 | 1 | 3 |
| GILD | Gilead Sciences, Inc. |
4 |
0.20% | 0.87% | +0.03% | 0 | 0 | 4 | 1 |
| NVO | Novo-Nordisk A S |
8 |
0.09% | 0.73% | −0.03% | 0 | 2 | 3 | 2 |
| AVTR | Avantor, Inc. |
6 |
0.15% | 1.4% | +0.03% | 0 | 3 | 3 | 1 |
| NTRA | Natera Inc. |
7 |
0.10% | 3.7% | +0.03% | 0 | 5 | 2 | 1 |
| SOLV | Solventum Corporation |
7 |
0.07% | 2.6% | +0.02% | 0 | 2 | 2 | 1 |
| CHE | Chemed Corp. New |
1 |
<0.01% | <0.01% | −0.02% | 0 | 0 | 0 | 1 |
| BMY | Bristol-Myers Squibb Co. |
12 |
0.12% | 1.4% | +0.02% | 1 | 5 | 5 | 0 |
| MRK | Merck & Co. Inc. |
13 |
0.04% | 1.4% | +0.02% | 1 | 2 | 6 | 3 |
| DXCM | Dexcom Inc. |
3 |
<0.01% | 0.65% | −0.02% | 0 | 0 | 2 | 3 |
| WAT | Waters Corp. |
3 |
0.11% | 3.0% | +0.02% | 0 | 0 | 3 | 0 |
| THC | Tenet Healthcare Corp. |
9 |
0.05% | 2.1% | −0.02% | 0 | 2 | 5 | 0 |
| PFE | Pfizer Inc. |
11 |
0.03% | 1.5% | −0.02% | 0 | 4 | 6 | 1 |
| BSX | Boston Scientific Corp. |
8 |
0.05% | 1.1% | +0.01% | 1 | 3 | 3 | 0 |
| BMRN | Biomarin Pharmaceutical, Inc. |
5 |
0.14% | 3.1% | −0.01% | 1 | 1 | 2 | 2 |
| IQV | Iqvia Hldgs Inc. |
5 |
0.25% | 2.1% | +0.01% | 0 | 1 | 3 | 1 |
| BIO | Bio Rad Labs Inc. |
4 |
0.04% | 1.9% | +0.01% | 0 | 2 | 2 | 1 |
| MOH | Molina Healthcare Inc. |
1 |
0.03% | 2.6% | +0.01% | 0 | 1 | 0 | 1 |
| DOCS | Doximity Inc. |
1 |
0.02% | 2.5% | +0.01% | 0 | 1 | 0 | 1 |
| UNH | Unitedhealth Group Inc. |
27 |
0.79% | 2.7% | +0.01% | 2 | 8 | 15 | 4 |
| JAZZ | Jazz Pharmaceuticals PLC |
3 |
<0.01% | 5.7% | −0.01% | 0 | 1 | 2 | 1 |
| MDGL | Madrigal Pharmaceuticals Inc. |
2 |
0.03% | 13.8% | −0.01% | 0 | 1 | 0 | 0 |
| ISRG | Intuitive Surgical Inc. |
6 |
0.05% | 1.0% | −0.01% | 0 | 2 | 2 | 2 |
| BDX | Becton Dickinson & Co. |
7 |
0.06% | 0.91% | +0.01% | 0 | 4 | 1 | 0 |
| A | Agilent Technologies Inc. |
5 |
0.06% | 1.6% | −0.01% | 0 | 0 | 4 | 1 |
| ROIV | Roivant Sciences Ltd |
3 |
0.05% | 1.6% | −0.01% | 0 | 1 | 2 | 0 |
| RVMD | Revolution Medicines Inc. |
3 |
0.04% | 3.3% | +0.01% | 0 | 3 | 0 | 1 |
| TEVA | Teva Pharmaceutical Inds Ltd |
9 |
0.03% | 0.92% | +0.01% | 2 | 1 | 3 | 1 |
| UHS | Universal Hlth Svcs Inc. |
4 |
0.09% | 1.4% | +0.01% | 1 | 1 | 2 | 1 |
| RMD | Resmed Inc. |
1 |
<0.01% | 0.43% | +0.01% | 1 | 0 | 0 | 0 |
| VTRS | Viatris Inc. |
6 |
0.06% | 2.2% | +0.01% | 1 | 2 | 2 | 0 |
| CRSP | Crispr Therapeutics AG |
2 |
0.02% | 1.6% | −0.01% | 0 | 0 | 2 | 1 |
| BHVN | Biohaven Ltd |
4 |
0.02% | 1.1% | +0.01% | 0 | 3 | 1 | 0 |
| LNTH | Lantheus Hldgs Inc. |
2 |
0.02% | 0.92% | +0.01% | 0 | 1 | 1 | 1 |
| UTHR | United Therapeutics Corp. |
3 |
<0.01% | 9.6% | −0.01% | 0 | 0 | 3 | 2 |
| CI | The Cigna Group |
9 |
0.51% | 2.7% | −0.01% | 0 | 4 | 5 | 2 |
| ICLR | Icon PLC |
4 |
0.05% | 0.81% | −0.01% | 0 | 1 | 3 | 0 |
| INSM | Insmed Inc. |
6 |
0.02% | 3.5% | −0.01% | 1 | 2 | 2 | 1 |
| ZTS | Zoetis Inc. |
9 |
0.16% | 1.4% | +0.01% | 1 | 2 | 4 | 0 |
| REGN | Regeneron Pharmaceuticals, Inc. |
7 |
0.18% | 0.38% | −0.01% | 2 | 0 | 5 | 1 |
| HROW | Harrow Health Inc. |
1 |
0.01% | 29.9% | +0.01% | 0 | 0 | 0 | 0 |
| WST | Western Alliance Bancorp |
8 |
0.06% | 2.5% | −0.01% | 1 | — | — | 0 |
| ILMN | Illumina Inc. |
8 |
0.04% | 2.3% | +0.01% | 1 | 1 | 5 | 0 |
| CNC | Centene Corp. Del |
5 |
0.16% | 1.6% | +0.01% | 0 | 1 | 3 | 1 |
| NVST | Envista Holdings Corporation |
3 |
0.03% | 1.4% | +0.01% | 0 | 1 | 2 | 0 |
| LLY | Eli Lilly & Co. |
12 |
0.14% | 1.1% | −0.01% | 2 | 5 | 5 | 0 |
| GERN | Geron Corp. |
1 |
<0.01% | <0.01% | −0.01% | 0 | 0 | 1 | 0 |
| FDMT | 4D Molecular Therapeutics In |
0 |
<0.01% | — | −0.01% | 0 | 0 | 0 | 2 |
| OSCR | Oscar Health Inc. |
6 |
0.03% | 2.7% | +0.00% | 1 | 1 | 2 | 0 |
| INCY | Incyte Corp. |
4 |
0.08% | 0.76% | +0.00% | 1 | 0 | 3 | 0 |
| TWST | Twist Bioscience Corp. |
2 |
0.02% | 1.1% | −0.00% | 0 | 1 | 1 | 0 |
| JNJ | Johnson & Johnson |
16 |
0.08% | 1.5% | +0.00% | 1 | 4 | 5 | 0 |
| NBIX | Neurocrine Biosciences, Inc. |
4 |
0.02% | 1.2% | −0.00% | 0 | 1 | 3 | 0 |
| MRNA | Moderna Inc. |
2 |
<0.01% | 0.38% | −0.00% | 0 | 1 | 1 | 1 |
| CNTA | Centessa Pharmaceuticals PLC |
3 |
<0.01% | 0.80% | +0.00% | 1 | 1 | 1 | 0 |
| MYGN | Myriad Genetics Inc. |
1 |
<0.01% | 0.67% | −0.00% | 0 | 0 | 1 | 0 |
| AMGN | Amgen Inc. |
8 |
<0.01% | 0.33% | −0.00% | 0 | 3 | 5 | 0 |
| GSK | Gsk PLC |
6 |
0.20% | 2.2% | +0.00% | 0 | — | — | 0 |
| ADPT | Adaptive Biotechnologies Cor |
2 |
0.01% | 0.55% | +0.00% | 0 | 1 | 0 | 0 |
| PODD | Insulet Corp. |
1 |
<0.01% | 0.87% | −0.00% | 0 | 0 | 0 | 1 |
| CAH | Cardinal Health Inc. |
7 |
0.02% | 2.4% | −0.00% | 0 | 1 | 3 | 1 |
| PTGX | Protagonist Therapeutics Inc. |
2 |
0.02% | 1.0% | +0.00% | 0 | 1 | 0 | 0 |
| ABT | Abbott Labs |
9 |
0.13% | 0.71% | −0.00% | 1 | 0 | 4 | 0 |
| IDXX | Idexx Laboratories Inc. |
4 |
0.16% | 2.0% | −0.00% | 0 | 2 | 1 | 0 |
| CRL | Charles Riv Labs Intl Inc. |
5 |
0.03% | 1.5% | −0.00% | 0 | 1 | 4 | 0 |
| BHC | Bausch Health Companies Inc. |
5 |
0.04% | 3.6% | +0.00% | 0 | 1 | 0 | 1 |
| IONS | Ionis Pharmaceuticals Inc. |
3 |
0.01% | 2.4% | −0.00% | 0 | 1 | 1 | 2 |
| BIIB | Biogen Inc. |
5 |
<0.01% | 4.6% | −0.00% | 0 | 0 | 5 | 0 |
| XRAY | Dentsply Sirona Inc. |
2 |
0.03% | 0.41% | +0.00% | 0 | 2 | 0 | 0 |
| ASND | Ascendis Pharma A/S |
4 |
<0.01% | 1.4% | +0.00% | 3 | 1 | 0 | 1 |
| IART | Integra Lifesciences Hldgs C |
2 |
<0.01% | 1.4% | +0.00% | 1 | 1 | 0 | 0 |
| VRTX | Vertex Pharmaceuticals Inc. |
5 |
<0.01% | 0.61% | +0.00% | 1 | 1 | 2 | 0 |
| TMO | Thermo Fisher Scientific Inc. |
15 |
0.22% | 1.6% | −0.00% | 1 | 3 | 11 | 0 |
| WVE | Wave Life Sciences Ltd |
1 |
<0.01% | 1.6% | +0.00% | 0 | 1 | 0 | 1 |
| VEEV | Veeva Sys Inc. |
5 |
0.03% | 0.68% | +0.00% | 0 | 2 | 3 | 2 |
| DNA | Ginkgo Bioworks Holdings Inc. |
3 |
<0.01% | 0.43% | +0.00% | 3 | 0 | 0 | 0 |
| RPRX | Royalty Pharma PLC |
4 |
0.03% | 1.9% | +0.00% | 0 | 4 | 0 | 0 |
| CRNX | Crinetics Pharmaceuticals In |
3 |
<0.01% | 0.38% | +0.00% | 0 | 1 | 0 | 0 |
| SHC | Sotera Health Co. |
3 |
0.01% | 2.7% | +0.00% | 0 | 1 | 0 | 2 |
| WGS | Genedx Holdings Corp. |
1 |
<0.01% | 4.1% | +0.00% | 0 | 0 | 0 | 0 |
| COO | Cooper Cos Inc. |
3 |
<0.01% | 0.27% | +0.00% | 1 | 1 | 1 | 0 |
| MTD | Mettler Toledo Ord |
3 |
0.09% | 1.6% | +0.00% | 0 | 1 | 2 | 0 |
| ALC | Alcon Inc. |
2 |
0.04% | 4.1% | +0.00% | 1 | 0 | 1 | 0 |
| CDNA | Caredx Inc. |
3 |
0.01% | 0.35% | +0.00% | 0 | 0 | 2 | 0 |
| NVS | Novartis AG |
5 |
0.10% | 0.33% | +0.00% | 0 | 1 | 3 | 1 |
| ALHC | Alignment Healthcare Inc. |
1 |
<0.01% | 0.47% | +0.00% | 0 | 1 | 0 | 0 |
| BKD | Brookdale Sr Living Inc. |
2 |
<0.01% | 0.17% | −0.00% | 0 | 1 | 1 | 0 |
| FMS | Fresenius Medical Care AG |
2 |
0.03% | 0.58% | +0.00% | 0 | 1 | 1 | 0 |
| PSNL | Personalis Inc. |
1 |
<0.01% | 0.35% | +0.00% | 0 | 1 | 0 | 0 |
| SGRY | Surgery Partners Inc. |
4 |
<0.01% | 8.3% | −0.00% | 1 | 0 | 3 | 1 |
| ARVN | Arvinas Inc. |
2 |
<0.01% | 3.5% | −0.00% | 0 | 1 | 1 | 0 |
| BLCO | Bausch Plus Lomb Corp. |
3 |
<0.01% | 3.8% | +0.00% | 1 | 0 | 1 | 0 |
| PRVA | Privia Health Group Inc. |
3 |
0.02% | 0.70% | +0.00% | 0 | 2 | 1 | 1 |
| VKTX | Viking Therapeutics Inc. |
3 |
<0.01% | 0.71% | −0.00% | 0 | 0 | 3 | 0 |
| SNDX | Syndax Pharmaceuticals Inc. |
4 |
<0.01% | 1.5% | −0.00% | 0 | 0 | 2 | 0 |
| BNTX | Biontech Se |
6 |
<0.01% | 1.3% | +0.00% | 4 | 1 | 1 | 0 |
| RCKT | Rocket Pharmaceuticals Inc. |
4 |
<0.01% | 0.61% | −0.00% | 0 | 2 | 2 | 0 |
| INDV | Indivior PLC |
2 |
<0.01% | 2.7% | +0.00% | 1 | 1 | 0 | 0 |
| ZBH | Zimmer Biomet Holdings, Inc. |
8 |
0.14% | 1.1% | −0.00% | 0 | 4 | 4 | 0 |
| PCVX | Vaxcyte Inc. |
5 |
<0.01% | 0.80% | +0.00% | 2 | 1 | 1 | 1 |
| INSP | Inspire Med Sys Inc. |
2 |
<0.01% | 0.16% | +0.00% | 0 | 0 | 2 | 0 |
| PGNY | Progyny Inc. |
2 |
<0.01% | 0.05% | −0.00% | 0 | 1 | 1 | 0 |
| ACHC | Acadia Healthcare Company In |
4 |
0.03% | 1.3% | −0.00% | 0 | 2 | 2 | 0 |
| IMVT | Immunovant Inc. |
5 |
<0.01% | 0.15% | −0.00% | 0 | 1 | 2 | 1 |
| ORIC | Oric Pharmaceuticals Inc. |
2 |
<0.01% | 0.45% | +0.00% | 1 | 0 | 0 | 1 |
| GPCR | Structure Therapeutics Inc. |
2 |
<0.01% | 0.66% | −0.00% | 0 | 1 | 1 | 1 |
| KYMR | Kymera Therapeutics Inc. |
2 |
<0.01% | 0.61% | +0.00% | 2 | 0 | 0 | 0 |
| BBIO | Bridgebio Pharma Inc. |
2 |
0.05% | 1.3% | +0.00% | 1 | 0 | 0 | 0 |
| ZLAB | Zai Lab Ltd |
2 |
<0.01% | 0.15% | +0.00% | 0 | 1 | 1 | 0 |
| ELAN | Elanco Animal Health, Inc. |
3 |
0.09% | 0.26% | −0.00% | 1 | 1 | 1 | 0 |
| EXEL | Exelixis Inc. |
3 |
0.05% | 7.3% | +0.00% | 0 | 1 | 2 | 0 |
| OPCH | Option Care Health Inc. |
3 |
<0.01% | 0.19% | +0.00% | 1 | 1 | 1 | 1 |
| ABBV | Abbvie Inc. |
10 |
0.01% | 0.43% | −0.00% | 0 | 3 | 4 | 1 |
| VCYT | Veracyte Inc. |
2 |
0.01% | 0.82% | +0.00% | 0 | 0 | 1 | 1 |
| FTRE | Fortrea Hldgs Inc. |
5 |
0.02% | 1.5% | −0.00% | 2 | 2 | 1 | 1 |
| QDEL | Quidelortho Corp. |
1 |
<0.01% | 1.4% | −0.00% | 0 | 0 | 1 | 1 |
| GH | Guardant Health Inc. |
1 |
<0.01% | 0.32% | +0.00% | 0 | 1 | 0 | 0 |
| HSIC | Henry Schein Inc. |
4 |
<0.01% | 0.42% | +0.00% | 2 | 1 | 1 | 0 |
| CGEM | Cullinan Therapeutics Inc. |
1 |
<0.01% | 0.36% | −0.00% | 0 | 0 | 1 | 0 |
| DYN | Dyne Therapeutics Inc. |
3 |
<0.01% | 0.87% | +0.00% | 1 | 1 | 0 | 0 |
| LQDA | Liquidia Corporation |
2 |
<0.01% | 1.5% | +0.00% | 0 | 2 | 0 | 0 |
| SYRE | Spyre Therapeutics Inc. |
1 |
<0.01% | 0.06% | −0.00% | 0 | 0 | 0 | 2 |
| CGON | Cg Oncology Inc. |
1 |
<0.01% | 3.2% | +0.00% | 0 | 1 | 0 | 0 |
| ORKA | Oruka Therapeutics Inc. |
1 |
<0.01% | 0.99% | +0.00% | 1 | 0 | 0 | 0 |
| ALNY | Alnylam Pharmaceuticals, Inc. |
3 |
0.07% | 1.9% | −0.00% | 0 | — | — | 1 |
| NAMS | Newamsterdam Pharma Company |
4 |
0.01% | 0.58% | −0.00% | 1 | 2 | 0 | 0 |
| DGX | Quest Diagnostics Inc. |
6 |
0.03% | 0.81% | +0.00% | 0 | 3 | 3 | 0 |
| ITGR | Integer Hldgs Corp. |
2 |
0.01% | 0.31% | +0.00% | 0 | 1 | 1 | 0 |
| GKOS | Glaukos Corp. |
3 |
<0.01% | 0.77% | +0.00% | 0 | 1 | 0 | 0 |
| NUVL | Nuvalent Inc. |
2 |
<0.01% | 0.58% | +0.00% | 1 | 1 | 0 | 0 |
| TERN | Terns Pharmaceuticals Inc. |
1 |
<0.01% | 0.91% | +0.00% | 1 | 0 | 0 | 1 |
| ESTA | Establishment Labs Hldgs Inc. |
2 |
<0.01% | 0.21% | −0.00% | 0 | 1 | 1 | 0 |
| LXEO | Lexeo Therapeutics Inc. |
2 |
<0.01% | 0.49% | −0.00% | 1 | 0 | 0 | 0 |
| BFLY | Butterfly Network Inc. |
2 |
<0.01% | 0.24% | +0.00% | 0 | 1 | 1 | 0 |
| BEAM | Beam Therapeutics Inc. |
3 |
0.03% | 0.82% | −0.00% | 0 | 1 | 2 | 0 |
| DHR | Danaher Corporation |
16 |
0.10% | 2.0% | +0.00% | 1 | 2 | 8 | 1 |
| SDGR | Schrodinger Inc. |
2 |
0.01% | 0.34% | −0.00% | 0 | 0 | 1 | 0 |
| EWTX | Edgewise Therapeutics Inc. |
3 |
<0.01% | 1.3% | +0.00% | 0 | 0 | 2 | 0 |
| PHAT | Phathom Pharmaceuticals Inc. |
1 |
<0.01% | 1.7% | +0.00% | 0 | 1 | 0 | 0 |
| CATX | Perspective Therapeutics Inc. |
2 |
<0.01% | 1.5% | +0.00% | 0 | 1 | 1 | 0 |
| AVAH | Aveanna Healthcare Hldgs Inc. |
1 |
<0.01% | 22.7% | +0.00% | 0 | 0 | 0 | 0 |
| WAY | Waystar Hldg Corp. |
0 |
<0.01% | — | −0.00% | 0 | 0 | 0 | 3 |
| TFX | Teleflex Incorporated |
1 |
<0.01% | 0.79% | +0.00% | 0 | 1 | 0 | 0 |
| NVAX | Novavax Inc. |
3 |
0.01% | 8.1% | −0.00% | 0 | 1 | 2 | 0 |
| ANAB | Anaptysbio Inc. |
2 |
<0.01% | 1.9% | +0.00% | 1 | 1 | 0 | 0 |
| TECH | Bio Techne Corp. |
5 |
0.04% | 0.64% | +0.00% | 0 | 2 | 3 | 0 |
| SYK | Stryker Corp. |
5 |
0.18% | 2.6% | +0.00% | 0 | 1 | 2 | 0 |
| ARGX | Argenx Se |
2 |
0.01% | 0.71% | +0.00% | 0 | 0 | 2 | 0 |
| PRME | Prime Medicine Inc. |
3 |
<0.01% | 0.12% | −0.00% | 0 | 0 | 1 | 0 |
| PGEN | Precigen Inc. |
1 |
<0.01% | 0.83% | −0.00% | 0 | 0 | 1 | 0 |
| LFST | Lifestance Health Group Inc. |
2 |
<0.01% | 0.27% | +0.00% | 1 | 0 | 1 | 0 |
| CYTK | Cytokinetics Inc. |
4 |
<0.01% | 1.5% | −0.00% | 0 | 1 | 1 | 1 |
| TGTX | Tg Therapeutics Inc. |
1 |
<0.01% | 8.9% | +0.00% | 0 | 0 | 0 | 0 |
| AHCO | Adapthealth Corp. |
1 |
<0.01% | 0.02% | −0.00% | 0 | 1 | 0 | 1 |
| TMDX | Transmedics Group Inc. |
2 |
<0.01% | 0.13% | +0.00% | 1 | 1 | 0 | 0 |
| APGE | Apogee Therapeutics Inc. |
1 |
<0.01% | 0.46% | −0.00% | 0 | 0 | 1 | 0 |
| BTI | British Amern Tob PLC |
2 |
<0.01% | 0.37% | +0.00% | 0 | 2 | 0 | 0 |
| MEDP | Medpace Holdings Inc. |
4 |
<0.01% | 0.81% | −0.00% | 0 | 3 | 1 | 0 |
| PEPG | Pepgen Inc. |
2 |
<0.01% | 0.15% | −0.00% | 1 | 0 | 0 | 0 |
| CRBP | Corbus Pharmaceuticals Hldgs |
0 |
<0.01% | — | −0.00% | 0 | 0 | 0 | 1 |
| HQY | Healthequity Inc. |
2 |
<0.01% | 0.08% | −0.00% | 0 | 0 | 1 | 0 |
| NGNE | Neurogene Inc. |
2 |
<0.01% | 0.49% | −0.00% | 0 | 0 | 2 | 0 |
| Masimo | Masimo Corp. |
3 |
0.02% | 0.35% | +0.00% | 0 | 1 | 0 | 1 |
| ETON | Eton Pharmaceuticals Inc. |
1 |
<0.01% | 2.8% | +0.00% | 0 | 1 | 0 | 0 |
| TECX | Tectonic Therapeutic Inc. |
1 |
<0.01% | 0.08% | +0.00% | 0 | 1 | 0 | 0 |
| LKFT | Galapagos NV |
2 |
<0.01% | 0.73% | +0.00% | 0 | 1 | 0 | 0 |
| GUTS | Fractyl Health Inc. |
1 |
<0.01% | 0.21% | −0.00% | 0 | 0 | 1 | 0 |
| Catalyst Pharmaceutic… | Catalyst Pharmaceuticals Inc. |
1 |
<0.01% | 0.37% | −0.00% | 0 | 0 | 1 | 0 |
| SPRY | Ars Pharmaceuticals Inc. |
2 |
<0.01% | 0.39% | +0.00% | 1 | 0 | 1 | 0 |
| PHG | Koninklijke Philips NV |
2 |
<0.01% | 0.51% | +0.00% | 0 | 0 | 2 | 0 |
| ENTA | Enanta Pharmaceuticals Inc. |
2 |
<0.01% | 4.4% | −0.00% | 0 | 2 | 0 | 0 |
| GRFS | Grifols S A |
3 |
<0.01% | 0.03% | +0.00% | 0 | 0 | 1 | 0 |
| IRWD | Ironwood Pharmaceuticals Inc. |
1 |
<0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 1 |
| NEOG | Neogen Corp. |
2 |
<0.01% | 0.20% | +0.00% | 0 | 2 | 0 | 0 |
| EW | Edwards Lifesciences Corp. |
7 |
<0.01% | 0.88% | +0.00% | 4 | 2 | 1 | 0 |
| HOLX | Hologic, Inc. |
4 |
<0.01% | 1.1% | −0.00% | 1 | 0 | 2 | 0 |
| OGN | Organon & Company |
2 |
<0.01% | 4.6% | −0.00% | 0 | 2 | 0 | 0 |
| GRAL | Grail Inc. |
2 |
<0.01% | 0.08% | −0.00% | 1 | 0 | 1 | 2 |
| ABSI | Absci Corp. |
1 |
<0.01% | 0.22% | +0.00% | 0 | 1 | 0 | 0 |
| PRTA | Prothena Corp. PLC |
1 |
<0.01% | 3.8% | −0.00% | 0 | 1 | 0 | 0 |
| ARDT | Ardent Health Partners Inc. |
2 |
<0.01% | 0.06% | +0.00% | 2 | 0 | 0 | 0 |
| Perrigo | Perrigo Company PLC |
2 |
<0.01% | 1.1% | +0.00% | 0 | 2 | 0 | 0 |
| AXGN | Axogen Inc. |
2 |
<0.01% | 1.6% | +0.00% | 0 | 0 | 0 | 0 |
| TYRA | Tyra Biosciences Inc. |
0 |
<0.01% | — | −0.00% | 0 | 0 | 0 | 1 |
| OCUL | Ocular Therapeutix Inc. |
1 |
<0.01% | 7.3% | +0.00% | 0 | 0 | 1 | 0 |
| USNA | Usana Health Sciences Inc. |
1 |
<0.01% | 0.13% | −0.00% | 0 | 1 | 0 | 0 |
| FOLD | Amicus Therapeutics Inc. |
2 |
<0.01% | 5.7% | −0.00% | 0 | 0 | 1 | 0 |
| RGEN | Repligen Corp. |
2 |
<0.01% | 0.04% | +0.00% | 0 | 1 | 1 | 0 |
| CON | Concentra Group Holdings Par |
1 |
<0.01% | 0.08% | +0.00% | 1 | 0 | 0 | 0 |
| URGN | Urogen Pharma Ltd |
4 |
<0.01% | 0.57% | −0.00% | 0 | 0 | 3 | 0 |
| CRMD | Cormedix Inc. |
1 |
<0.01% | 0.06% | +0.00% | 0 | 0 | 0 | 0 |
| NMRA | Neumora Therapeutics Inc. |
1 |
<0.01% | 1.2% | +0.00% | 0 | 0 | 0 | 0 |
| VYGR | Voyager Therapeutics Inc. |
1 |
<0.01% | 0.07% | −0.00% | 0 | 0 | 0 | 0 |
| IRTC | Irhythm Technologies Inc. |
0 |
<0.01% | — | −0.00% | 0 | 0 | 0 | 1 |
| LIVN | Livanova PLC |
1 |
<0.01% | 1.3% | −0.00% | 0 | 0 | 1 | 0 |
| AXSM | Axsome Therapeutics Inc. |
3 |
<0.01% | 0.50% | −0.00% | 0 | 1 | 1 | 0 |
| CERS | Cerus Corp. |
1 |
<0.01% | 0.29% | −0.00% | 0 | 0 | 1 | 0 |
| RARE | Ultragenyx Pharmaceutical In |
4 |
<0.01% | 0.57% | +0.00% | 2 | 0 | 2 | 0 |
| RYTM | Rhythm Pharmaceuticals Inc. |
1 |
<0.01% | 4.4% | +0.00% | 0 | 0 | 1 | 0 |
| COLL | Collegium Pharmaceutical Inc. |
1 |
<0.01% | 1.2% | −0.00% | 0 | 1 | 0 | 2 |
| EOLS | Evolus Inc. |
1 |
<0.01% | 0.20% | +0.00% | 0 | 0 | 0 | 0 |
| PNTG | Pennant Group Inc. |
1 |
<0.01% | 0.03% | +0.00% | 0 | 0 | 1 | 0 |
| COR | Cencora Inc. |
1 |
<0.01% | 0.26% | −0.00% | 0 | 0 | 1 | 1 |
| MRVI | Maravai Lifesciences Hldgs I |
1 |
<0.01% | 0.05% | −0.00% | 0 | 0 | 0 | 1 |
| ZNTL | Zentalis Pharmaceuticals Inc. |
1 |
<0.01% | 0.59% | +0.00% | 1 | 0 | 0 | 0 |
| IOVA | Iovance Biotherapeutics Inc. |
2 |
<0.01% | 1.9% | +0.00% | 0 | 1 | 0 | 1 |
| PHVS | Pharvaris N V |
1 |
<0.01% | 0.25% | −0.00% | 0 | 0 | 0 | 0 |
| NUVB | Nuvation Bio Inc. |
3 |
<0.01% | 0.12% | −0.00% | 0 | 0 | 0 | 0 |
| QURE | Uniqure NV |
1 |
<0.01% | 0.17% | +0.00% | 1 | 0 | 0 | 0 |
| ATRC | Atricure Inc. |
1 |
<0.01% | 4.3% | +0.00% | 0 | 1 | 0 | 0 |
| MIRM | Mirum Pharmaceuticals Inc. |
2 |
<0.01% | 0.89% | +0.00% | 0 | 0 | 0 | 0 |
| RXRX | Recursion Pharmaceuticals Inc. |
1 |
0.02% | 2.0% | −0.00% | 0 | 1 | 0 | 0 |
| PBH | Prestige Consmr Healthcare I |
3 |
0.01% | 0.83% | −0.00% | 0 | 1 | 2 | 0 |
| VSTM | Verastem Inc. |
1 |
<0.01% | 0.09% | −0.00% | 1 | 0 | 0 | 1 |
| IDYA | Ideaya Biosciences Inc. |
2 |
<0.01% | 2.9% | +0.00% | 0 | 2 | 0 | 0 |
| NRIX | Nurix Therapeutics Inc. |
3 |
<0.01% | 0.69% | −0.00% | 0 | 1 | 1 | 1 |
| Enhabit | Enhabit Inc. |
1 |
<0.01% | 0.88% | −0.00% | 0 | 1 | 0 | 0 |
| RZLT | Rezolute Inc. |
1 |
<0.01% | 0.38% | +0.00% | 1 | 0 | 0 | 0 |
| BRKR | Bruker Corp. |
1 |
<0.01% | 0.01% | +0.00% | 1 | 0 | 0 | 0 |
| STXS | Stereotaxis Inc. |
1 |
<0.01% | 6.6% | +0.00% | 0 | 0 | 0 | 0 |
| SNN | Smith & Nephew PLC |
1 |
<0.01% | 0.04% | +0.00% | 1 | 0 | 0 | 0 |
| BIOA | Bioage Labs Inc. |
1 |
<0.01% | 0.03% | +0.00% | 1 | 0 | 0 | 0 |
| DMAC | Diamedica Therapeutics Inc. |
1 |
<0.01% | 0.27% | +0.00% | 0 | 1 | 0 | 0 |
| SRTA | Blade Air Mobility Inc. |
1 |
<0.01% | 0.19% | −0.00% | 0 | 1 | 0 | 0 |
| NVCR | Novocure Ltd |
2 |
<0.01% | 0.62% | −0.00% | 0 | 1 | 0 | 0 |
| VNDA | Vanda Pharmaceuticals Inc. |
2 |
<0.01% | 0.55% | −0.00% | 0 | 0 | 2 | 0 |
| ACAD | Acadia Pharmaceuticals Inc. |
1 |
<0.01% | 5.0% | −0.00% | 0 | 1 | 0 | 0 |
| BCYC | Bicycle Therapeutics PLC |
4 |
<0.01% | 0.24% | +0.00% | 1 | 0 | 1 | 0 |
| FULC | Fulcrum Therapeutics Inc. |
0 |
<0.01% | — | −0.00% | 0 | 0 | 0 | 1 |
| INBX | Inhibrx Biosciences Inc. |
1 |
<0.01% | 0.10% | +0.00% | 0 | 0 | 0 | 0 |
| ANRO | Alto Neuroscience Inc. |
2 |
<0.01% | 0.11% | +0.00% | 1 | 0 | 1 | 0 |
| ANGO | Angiodynamics Inc. |
1 |
<0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 |
| RDNT | Radnet Inc. |
2 |
<0.01% | 0.01% | +0.00% | 0 | 1 | 0 | 0 |
| HIMS | Hims & Hers Health Inc. |
2 |
<0.01% | 0.10% | −0.00% | 0 | 1 | 0 | 0 |
| DNTH | Dianthus Therapeutics Inc. |
1 |
<0.01% | 4.1% | +0.00% | 0 | 0 | 0 | 0 |
| IPSC | Century Therapeutics Inc. |
1 |
<0.01% | 0.69% | −0.00% | 0 | 0 | 0 | 0 |
| LRMR | Larimar Therapeutics Inc. |
1 |
<0.01% | 0.76% | −0.00% | 0 | 0 | 1 | 0 |
| ATEC | Alphatec Hldgs Inc. |
1 |
<0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 |
| TRVI | Trevi Therapeutics Inc. |
2 |
<0.01% | 0.74% | +0.00% | 0 | 0 | 1 | 0 |
| AQST | Aquestive Therapeutics Inc. |
1 |
<0.01% | 0.69% | +0.00% | 0 | 1 | 0 | 0 |
| ALLO | Allogene Therapeutics Inc. |
2 |
<0.01% | 0.35% | +0.00% | 0 | 1 | 1 | 0 |
| IVVD | Invivyd Inc. |
2 |
<0.01% | 0.13% | −0.00% | 0 | 0 | 0 | 0 |
| Kalvista Pharmaceutic… | Kalvista Pharmaceuticals Inc. |
1 |
<0.01% | 2.0% | −0.00% | 0 | 0 | 1 | 0 |
| ABCL | Abcellera Biologics Inc. |
1 |
<0.01% | 0.35% | +0.00% | 0 | 1 | 0 | 0 |
| COGT | Cogent Biosciences Inc. |
2 |
<0.01% | 0.28% | −0.00% | 0 | 1 | 1 | 0 |
| AMLX | Amylyx Pharmaceuticals Inc. |
1 |
<0.01% | 0.02% | +0.00% | 0 | 0 | 0 | 0 |
| AMN | Amn Healthcare Svcs Inc. |
1 |
<0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 |
| XENE | Xenon Pharmaceuticals Inc. |
3 |
<0.01% | 1.4% | +0.00% | 0 | 1 | 0 | 0 |
| ANIP | Ani Pharmaceuticals Inc. |
0 |
<0.01% | — | −0.00% | 0 | 0 | 0 | 1 |
| AGIO | Agios Pharmaceuticals Inc. |
1 |
0.02% | 1.2% | −0.00% | 0 | 1 | 0 | 0 |
| ENOV | Enovis Corporation |
2 |
<0.01% | 0.04% | −0.00% | 0 | 0 | 1 | 0 |
| MBX | Mbx Biosciences Inc. |
2 |
<0.01% | 0.01% | +0.00% | 2 | 0 | 0 | 0 |
| KURA | Kura Oncology Inc. |
1 |
<0.01% | 1.9% | −0.00% | 0 | 0 | 1 | 0 |
| EDIT | Editas Medicine Inc. |
2 |
<0.01% | 0.13% | +0.00% | 0 | 1 | 1 | 0 |
| TALK | Talkspace Inc. |
3 |
<0.01% | 0.49% | −0.00% | 1 | 1 | 0 | 0 |
| RAPP | Rapport Therapeutics Inc. |
0 |
<0.01% | — | −0.00% | 0 | 0 | 0 | 2 |
| PRCT | Procept Biorobotics Corp. |
0 |
<0.01% | — | −0.00% | 0 | 0 | 0 | 1 |
| CNTX | Context Therapeutics Inc. |
1 |
<0.01% | 0.74% | −0.00% | 0 | 0 | 1 | 0 |
| ALGN | Align Technology Inc. |
5 |
<0.01% | 0.32% | −0.00% | 0 | 3 | 1 | 0 |
| ARCT | Arcturus Therapeutics Holdings |
1 |
<0.01% | 0.45% | −0.00% | 0 | 1 | 0 | 0 |
| VMD | Viemed Healthcare Inc. |
1 |
<0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 |
| LFCR | Lifecore Biomedical Inc. |
1 |
<0.01% | 4.7% | −0.00% | 0 | 1 | 0 | 0 |
| BCAX | Bicara Therapeutics Inc. |
2 |
<0.01% | <0.01% | +0.00% | 2 | 0 | 0 | 0 |
| DSGN | Design Therapeutics Inc. |
0 |
<0.01% | — | −0.00% | 0 | 0 | 0 | 1 |
| SUPN | Supernus Pharmaceuticals, Inc. |
1 |
<0.01% | 0.97% | +0.00% | 0 | 1 | 0 | 0 |
| LZAGY | Lonza Group Adr |
1 |
<0.01% | 0.96% | +0.00% | 0 | 0 | 1 | 0 |
| AORT | Artivion Inc. |
1 |
<0.01% | 0.03% | +0.00% | 0 | 1 | 0 | 0 |
| CERT | Certara Inc. |
1 |
<0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 |
| ZBIO | Zenas Biopharma Inc. |
1 |
<0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 |
| PYXS | Pyxis Oncology Inc. |
1 |
<0.01% | 0.08% | +0.00% | 1 | 0 | 0 | 0 |
| LH | Labcorp Holdings Inc. |
3 |
0.01% | 1.2% | +0.00% | 0 | 1 | 2 | 0 |
| TVTX | Travere Therapeutics Inc. |
1 |
<0.01% | 0.20% | +0.00% | 0 | 0 | 0 | 0 |
| ALKS | Alkermes PLC |
4 |
<0.01% | 1.5% | −0.00% | 0 | 0 | 3 | 0 |
| ALVO | Alvotech SA |
2 |
<0.01% | 0.25% | +0.00% | 1 | 0 | 0 | 0 |
| STOK | Stoke Therapeutics Inc. |
2 |
<0.01% | 0.40% | −0.00% | 0 | 0 | 0 | 0 |
| BCRX | Biocryst Pharmaceuticals Inc. |
1 |
<0.01% | 1.2% | +0.00% | 0 | 0 | 1 | 0 |
| BDTX | Black Diamond Therapeutics I |
1 |
<0.01% | 0.13% | +0.00% | 1 | 0 | 0 | 0 |
| EHC | Encompass Health Corp. |
2 |
<0.01% | 0.04% | +0.00% | 0 | 0 | 1 | 0 |
| AUTL | Autolus Therapeutics PLC |
1 |
<0.01% | 0.42% | +0.00% | 0 | 1 | 0 | 0 |
| CMPS | Compass Pathways PLC |
2 |
<0.01% | 0.24% | −0.00% | 0 | 0 | 1 | 0 |
| GMAB | Genmab A/S |
1 |
<0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 |
| XOMA | Xoma Corp. Del |
1 |
<0.01% | 1.1% | +0.00% | 0 | 0 | 0 | 0 |
| CVRX | Cvrx Inc. |
1 |
<0.01% | 0.01% | −0.00% | 0 | 1 | 0 | 0 |
| Inmode | Inmode Ltd |
1 |
<0.01% | 0.02% | −0.00% | 0 | 0 | 1 | 0 |
| BWAY | Brainsway Ltd |
1 |
<0.01% | 0.55% | +0.00% | 0 | 0 | 1 | 0 |
| ALDX | Aldeyra Therapeutics Inc. |
1 |
<0.01% | 0.16% | +0.00% | 0 | 0 | 0 | 0 |
| HSTM | Healthstream Inc. |
1 |
<0.01% | 0.03% | +0.00% | 0 | 1 | 0 | 0 |
| EMBC | Embecta Corp. |
2 |
<0.01% | 0.19% | −0.00% | 0 | 0 | 2 | 0 |
| HALO | Halozyme Therapeutics |
1 |
<0.01% | 0.44% | +0.00% | 0 | 1 | 0 | 0 |
| MLYS | Mineralys Therapeutics Inc. |
1 |
<0.01% | 0.42% | +0.00% | 0 | 1 | 0 | 0 |
| DCGO | Docgo Inc. |
0 |
<0.01% | — | −0.00% | 0 | 0 | 0 | 1 |
| Nano-X Imaging | Nano-X Imaging Ltd |
1 |
<0.01% | 0.01% | −0.00% | 0 | 1 | 0 | 0 |
| ADGM | Adagio Med Hldgs Inc. |
1 |
<0.01% | 0.05% | +0.00% | 1 | 0 | 0 | 0 |
| ENSG | Ensign Group Inc. |
1 |
<0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 |
| INGN | Inogen Inc. |
1 |
<0.01% | 0.48% | +0.00% | 0 | 0 | 0 | 0 |
| GANX | Gain Therapeutics Inc. |
1 |
<0.01% | 0.04% | +0.00% | 0 | 0 | 0 | 0 |
| TSHA | Taysha Gene Therapies Inc. |
1 |
<0.01% | 0.21% | −0.00% | 0 | 0 | 0 | 0 |
| ONC | Beigene Ltd |
1 |
<0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 |
| Select Med | Select Med Hldgs Corp. |
1 |
<0.01% | 0.02% | +0.00% | 0 | 1 | 0 | 0 |
| COYA | Coya Therapeutics Inc. |
1 |
<0.01% | 0.34% | +0.00% | 0 | 0 | 0 | 0 |
| RLMD | Relmada Therapeutics Inc. |
3 |
<0.01% | 0.19% | −0.00% | 0 | 0 | 1 | 0 |
| APRE | Aprea Therapeutics Inc. |
1 |
<0.01% | 0.09% | −0.00% | 0 | 0 | 0 | 0 |
| RDY | Dr Reddy's Laboratories Ltd |
1 |
<0.01% | 0.21% | +0.00% | 0 | 1 | 0 | 0 |
| CRBU | Caribou Biosciences Inc. |
1 |
<0.01% | 0.02% | +0.00% | 0 | 0 | 0 | 0 |
| Esperion Therapeutics | Esperion Therapeutics Inc. Ne |
1 |
<0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 |
| VCEL | Vericel Corp. |
1 |
<0.01% | 0.01% | −0.00% | 0 | 0 | 0 | 0 |
| TNDM | Tandem Diabetes Care Inc. |
1 |
<0.01% | 2.0% | +0.00% | 0 | 0 | 0 | 0 |
| INFU | Infusystem Hldgs Inc. |
1 |
<0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 |
| RFL | Rafael Holding |
1 |
<0.01% | 0.09% | +0.00% | 0 | 0 | 1 | 0 |
| ARAY | Accuray Inc. |
1 |
<0.01% | 0.52% | −0.00% | 0 | 0 | 0 | 0 |
| FHTX | Foghorn Therapeutics Inc. |
1 |
<0.01% | 0.08% | +0.00% | 0 | 0 | 1 | 0 |
| Compugen | Compugen Ltd |
3 |
<0.01% | 0.08% | +0.00% | 0 | 2 | 1 | 0 |
| CMPX | Compass Therapeutics Inc. |
1 |
<0.01% | 0.05% | +0.00% | 0 | 0 | 0 | 0 |
| APYX | Apyx Med Corp. |
1 |
<0.01% | 0.01% | −0.00% | 0 | 0 | 0 | 0 |
| PRQR | Proqr Therapeutics N V |
1 |
<0.01% | 0.39% | +0.00% | 0 | 0 | 0 | 0 |
| XERS | Xeris Biopharma Holdings Inc. |
1 |
<0.01% | 0.04% | +0.00% | 0 | 0 | 0 | 0 |
| ABEO | Abeona Therapeutics Inc. |
1 |
<0.01% | 0.01% | +0.00% | 1 | 0 | 0 | 0 |
| RCUS | Arcus Biosciences Inc. |
1 |
<0.01% | 0.93% | −0.00% | 0 | 1 | 0 | 0 |
| BTSG | Brightspring Health Svcs Inc. |
1 |
<0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 |
| TAK | Takeda Pharmaceutical Co. Ltd |
1 |
<0.01% | 0.45% | +0.00% | 0 | 0 | 1 | 0 |
| ACRV | Acrivon Therapeutics Inc. |
1 |
<0.01% | 0.19% | +0.00% | 0 | 0 | 1 | 0 |
| CGC | Canopy Growth Corp. |
1 |
<0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 |
| ALEC | Alector Inc. |
1 |
<0.01% | 1.0% | −0.00% | 0 | 0 | 0 | 0 |
| LTRN | Lantern Pharma Inc. |
1 |
<0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 |
| OSUR | Orasure Technologies Inc. |
1 |
<0.01% | 0.14% | −0.00% | 0 | 0 | 1 | 0 |
| MMSI | Merit Med Sys Inc. |
1 |
<0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 |
| CCCC | C4 Therapeutics Inc. |
1 |
<0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 |
| ADCT | Adc Therapeutics SA |
1 |
<0.01% | 0.15% | −0.00% | 0 | 0 | 0 | 0 |
| ALT | Altimmune Inc. |
1 |
<0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 |
| ARDX | Ardelyx Inc. |
1 |
<0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 |
| REPL | Replimune Group Inc. |
1 |
<0.01% | <0.01% | +0.00% | 0 | 0 | 1 | 0 |
| KRYS | Krystal Biotech Inc. |
1 |
<0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 |
| GALT | Galectin Therapeutics Inc. |
1 |
<0.01% | <0.01% | +0.00% | 0 | 0 | 1 | 0 |
| IBIO | Ibio Inc. |
1 |
<0.01% | 0.14% | +0.00% | 0 | 0 | 0 | 0 |
| ARQT | Arcutis Biotherapeutics Inc. |
1 |
<0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 |
| ACRS | Aclaris Therapeutics Inc. |
1 |
<0.01% | 0.09% | +0.00% | 0 | 0 | 0 | 0 |
| GMED | Globus Med Inc. |
1 |
<0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 |
| CYH | Community Health Sys Inc. New |
1 |
<0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 |